Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

PAD tied to higher prevalence of LV diastolic dysfunction

Yanaka K et al. J Cardiol. 2019 Feb 18. doi: 10.1016/j.jjcc.2019.01.011

Key clinical point: Patients with peripheral artery disease should be evaluated not only for left ventricular systolic but also diastolic function in echocardiography.

Major finding: Multivariate analysis showed that peripheral artery disease was an independent predictor of left ventricular diastolic dysfunction (adjusted odds ratio. 1.77; P = .01).

Study details: The study enrolled 1,121 patients with preserved left ventricular systolic function.

Disclosures: The authors reported that they had no disclosures.

Citation:

Yanaka K et al. J Cardiol. 2019 Feb 18. doi: 10.1016/j.jjcc.2019.01.011.

This Week's Must Reads

CVD Event Rates Among Adults with PCSK9 Inhibition, Cardiovasc Drugs Ther; ePub 2019 Feb 11; Colantonio, et al

Statin Adherence & Mortality in Patients with ASCVD, JAMA Cardiol; ePub 2019 Feb 13; Rodriguez, et al

Physician Monitoring & LDL-C Follow-Up Testing , Prev Med; 2019 Apr; Dansinger, Williams, et al

CVD Prevalence in HeFH After Statin Treatment, Atherosclerosis; ePub 2019 Feb 12; Perez-Calahorra, et al

Must Reads in Peripheral Vascular Disorders

PAD tied to higher prevalence of LV diastolic dysfunction, Yanaka K et al. J Cardiol. 2019 Feb 18. doi: 10.1016/j.jjcc.2019.01.011

Diabetic kidney disease, retinopathy associated with PAD in patients with foot ulcers, Megallaa MH et al. Diabetes Metab Syndr. 2019 Mar-Apr;13(2):1287-92.

Smoking as PAD Risk Factor in African Americans, J Am Heart Assoc; ePub 2019 Jan 23; Clark III, et al

Effect of Statin Intensity on PAD Outcomes, Circulation; ePub 2018 Jan 12; Arya, et al